Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$54.9 - $105.21 $12.5 Million - $24 Million
-227,810 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$105.0 - $178.37 $31.9 Million - $54.3 Million
-304,265 Reduced 57.18%
227,810 $24 Million
Q2 2021

Aug 06, 2021

BUY
$125.11 - $180.0 $66.6 Million - $95.8 Million
532,075 New
532,075 $94.2 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $1.7B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Tt International Asset Management LTD Portfolio

Follow Tt International Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tt International Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tt International Asset Management LTD with notifications on news.